Cargando…

Intestinal complications in patients with Crohn’s disease in the Brazilian public healthcare system between 2011 and 2020

BACKGROUND: This is a secondary database study using the Brazilian public healthcare system database. AIM: To describe intestinal complications (ICs) of patients in the Brazilian public healthcare system with Crohn’s disease (CD) who initiated and either only received conventional therapy (CVT) or a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sassaki, Ligia Yukie, Martins, Adalberta Lima, Galhardi-Gasparini, Rodrigo, Saad-Hossne, Rogerio, Ritter, Alessandra Mileni Versut, Barreto, Tania Biatti, Marcolino, Taciana, Balula, Bruno, Yang-Santos, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237144/ https://www.ncbi.nlm.nih.gov/pubmed/37274050 http://dx.doi.org/10.12998/wjcc.v11.i14.3224

Ejemplares similares

Intestinal complications in Brazilian patients with ulcerative colitis treated with conventional therapy between 2011 and 2020
por: Martins, Adalberta Lima, et al.
Publicado: (2023)

Inflammatory bowel disease epidemiology in São Paulo State, Brazil
por: Gasparini, Rodrigo Galhardi, et al.
Publicado: (2018)

Quality of care in patients with inflammatory bowel disease from a public health center in Brazil
por: Takamune, Debora Mayumi, et al.
Publicado: (2022)

Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2020)

Anti-TNF Exposure during Pregnancy in Crohn's Disease Patients
por: Silva, Elen Farinelli de Campos, et al.
Publicado: (2018)

Non-Hodgkin's Lymphoma: An Important Differential Diagnosis in Inflammatory Bowel Disease
por: Saad-Hossne, Rogerio, et al.
Publicado: (2018)

Leukocytoclastic Vasculitis as an Extraintestinal Manifestation of Crohn's Disease
por: Rocha, Thiara Barcelos, et al.
Publicado: (2021)

Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease
por: Moutinho, Bruna Damásio, et al.
Publicado: (2020)

Pulmonary Tuberculosis After Therapy with Anti-Tumor Necrosis Factor (TNF) for Crohn Disease: A Case Report
por: da Silva, Douglas Inomata Cardoso, et al.
Publicado: (2021)

Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature
por: Grillo, Thais Gagno, et al.
Publicado: (2021)

Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil
por: Cassol, Ornella Sari, et al.
Publicado: (2022)

Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn’s Disease: A Cross-Sectional Multicentric Latin American Study
por: de Souza, Letícia Rodrigues, et al.
Publicado: (2023)

Immune Thrombocytopenic Purpura as an Extraintestinal Manifestation in a Patient with Ulcerative Colitis
por: de Medeiros Dutra, Renata, et al.
Publicado: (2022)

Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey
por: Queiroz, Natália Sousa Freitas, et al.
Publicado: (2021)

Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study
por: de Campos Silva, Elen Farinelli, et al.
Publicado: (2020)

Modern surgical strategies for perianal Crohn's disease
por: Zabot, Gilmara Pandolfo, et al.
Publicado: (2020)

Endoscopic Postoperative Recurrence Rates in Crohn's Disease in Korea: The Beginning of a New Approach?
por: Kotze, Paulo Gustavo, et al.
Publicado: (2014)

Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report
por: Garate, Ana Lorena Sousa de Vasconcelos, et al.
Publicado: (2021)

Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil
por: Zaltman, Cyrla, et al.
Publicado: (2021)

Clinical and Psychological Factors Associated with Addiction and Compensatory Use of Facebook Among Patients with Inflammatory Bowel Disease: A Cross-Sectional Study
por: Cury, Giovana Signorelli Astolfi, et al.
Publicado: (2022)

Management of inflammatory bowel disease and serum level of infliximab in newborn exposed to anti-TNF therapy during pregnancy: Case report and literature review
por: de Aragão, Maria Cecília, et al.
Publicado: (2021)

Escherichia coli from Crohn’s disease patient displays virulence features of enteroinvasive (EIEC), enterohemorragic (EHEC), and enteroaggregative (EAEC) pathotypes
por: da Silva Santos, Ana Carolina, et al.
Publicado: (2015)

Small Intestinal Hemangioma: A Case Report
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2021)

Mucosa-associated but not luminal Escherichia coli is augmented in Crohn’s disease and ulcerative colitis
por: de Souza, Helton Luis, et al.
Publicado: (2012)

MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2021)

Facing Terminal Ileitis: Going Beyond Crohn’s Disease
por: Goulart, Ricardo de Alvares, et al.
Publicado: (2016)

Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil
por: Parra, Rogerio S, et al.
Publicado: (2019)

Access to biologicals in Crohn’s disease in ten European countries
por: Péntek, Márta, et al.
Publicado: (2017)

Fungal dysbiosis predicts the diagnosis of pediatric Crohn’s disease
por: El Mouzan, Mohammad I, et al.
Publicado: (2018)

A Novel Capsule Endoscopic Score for Crohn’s Disease
por: Omori, Teppei, et al.
Publicado: (2020)

The Impact of Confounders on Symptom–Endoscopic Discordances in Crohn’s Disease
por: Rajan, Anjana, et al.
Publicado: (2023)

Vedolizumab in Mild-to-Moderate Crohn’s Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study
por: Dotti, Adriana Zanoni, et al.
Publicado: (2023)

Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn’s disease
por: Gupta, Neera, et al.
Publicado: (2018)

Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease
por: Sollelis, Elisa, et al.
Publicado: (2019)

Physical Activity in Adults With Crohn’s Disease: A Scoping Review
por: Neal, Whitney N, et al.
Publicado: (2022)

Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study
por: Perin, Ramir Luan, et al.
Publicado: (2022)

The prevalence and phenotype in Brazilian patients with inflammatory bowel disease
por: Lima Martins, Adalberta, et al.
Publicado: (2018)

Temporal trends in the misdiagnosis rates between Crohn’s disease and intestinal tuberculosis
por: Seo, Hyungil, et al.
Publicado: (2017)

Fecal MicroRNAs Show Promise as Noninvasive Crohn’s Disease Biomarkers
por: Wohnhaas, Christian T, et al.
Publicado: (2020)

Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patients
por: Foster, Alice Jane, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_chk2t146mka34d6vhrti4d9mo3